525 related articles for article (PubMed ID: 10710070)
1. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients.
Cotler SJ; Taylor SL; Gretch DR; Bronner MP; Rizk R; Perkins JD; Carithers RL
Am J Gastroenterol; 2000 Mar; 95(3):753-9. PubMed ID: 10710070
[TBL] [Abstract][Full Text] [Related]
2. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study.
Delladetsima I; Psichogiou M; Sypsa V; Psimenou E; Kostakis A; Hatzakis A; Boletis JN
Am J Kidney Dis; 2006 Feb; 47(2):309-16. PubMed ID: 16431260
[TBL] [Abstract][Full Text] [Related]
3. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications.
Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL
Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors.
Gaglio PJ; Malireddy S; Levitt BS; Lapointe-Rudow D; Lefkowitch J; Kinkhabwala M; Russo MW; Emond JC; Brown RS
Liver Transpl; 2003 Oct; 9(10):1028-35. PubMed ID: 14526396
[TBL] [Abstract][Full Text] [Related]
5. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern?
Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J
Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875
[TBL] [Abstract][Full Text] [Related]
6. [Clinical and histological features of fibrosing cholestatic hepatitis].
Zhu Y; Luo K; Yu L
Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):434-6. PubMed ID: 12502446
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation and hepatitis C virus. Results in a Spanish center since 1989.
Loinaz C; Lumbreras C; Moreno E; Colina F; Fuertes A; Gómez R; Jiménez C; González-Pinto I; García I; Rojas J; Bellorín C
Hepatogastroenterology; 2001; 48(41):1435-42. PubMed ID: 11677981
[TBL] [Abstract][Full Text] [Related]
8. The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection.
Neff GW; Shire N; Ruiz P; O'Brien C; Garcia M; Dela Garza J; Rudich SR; Reddy KR
Transplant Proc; 2005 Dec; 37(10):4397-402. PubMed ID: 16387130
[TBL] [Abstract][Full Text] [Related]
9. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
Watt KD; Lyden ER; Gulizia JM; McCashland TM
Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
[TBL] [Abstract][Full Text] [Related]
10. Rapidly progressive fibrosing cholestatic hepatitis--hepatitis C virus in HIV coinfection.
Rosenberg PM; Farrell JJ; Abraczinskas DR; Graeme-Cook FM; Dienstag JL; Chung RT
Am J Gastroenterol; 2002 Feb; 97(2):478-83. PubMed ID: 11866292
[TBL] [Abstract][Full Text] [Related]
11. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.
Davies SE; Portmann BC; O'Grady JG; Aldis PM; Chaggar K; Alexander GJ; Williams R
Hepatology; 1991 Jan; 13(1):150-7. PubMed ID: 1988336
[TBL] [Abstract][Full Text] [Related]
12. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation.
Schluger LK; Sheiner PA; Thung SN; Lau JY; Min A; Wolf DC; Fiel I; Zhang D; Gerber MA; Miller CM; Bodenheimer HC
Hepatology; 1996 May; 23(5):971-6. PubMed ID: 8621177
[TBL] [Abstract][Full Text] [Related]
13. Early histologic changes in fibrosing cholestatic hepatitis C.
Dixon LR; Crawford JM
Liver Transpl; 2007 Feb; 13(2):219-26. PubMed ID: 17205558
[TBL] [Abstract][Full Text] [Related]
14. Intrahepatic cytokine profiles associated with posttransplantation hepatitis C virus-related liver injury.
Zekry A; Bishop GA; Bowen DG; Gleeson MM; Guney S; Painter DM; McCaughan GW
Liver Transpl; 2002 Mar; 8(3):292-301. PubMed ID: 11910576
[TBL] [Abstract][Full Text] [Related]
15. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
[TBL] [Abstract][Full Text] [Related]
16. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation.
Cho JY; Suh KS; Lee HW; Cho EH; Yang SH; Cho YB; Yi NJ; Kim MA; Jang JJ; Lee KU
Transpl Int; 2006 Oct; 19(10):807-13. PubMed ID: 16961772
[TBL] [Abstract][Full Text] [Related]
17. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
Charlton M; Kasparova P; Weston S; Lindor K; Maor-Kendler Y; Wiesner RH; Rosen CB; Batts KP
Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228
[TBL] [Abstract][Full Text] [Related]
18. Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.
Neumann UP; Berg T; Bahra M; Seehofer D; Langrehr JM; Neuhaus R; Radke C; Neuhaus P
J Hepatol; 2004 Nov; 41(5):830-6. PubMed ID: 15519657
[TBL] [Abstract][Full Text] [Related]
19. Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.
Berenguer M; Aguilera V; Prieto M; San Juan F; Rayón JM; Benlloch S; Berenguer J
Liver Transpl; 2006 May; 12(5):762-7. PubMed ID: 16528713
[TBL] [Abstract][Full Text] [Related]
20. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
Pissaia A; Borderie D; Bernard D; Scatton O; Calmus Y; Conti F
Transplant Proc; 2009 Mar; 41(2):679-81. PubMed ID: 19328955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
